Latest Articles Hero Image

Latest Articles

Researcher Profile: Gokul Swaminathan

Dr. Gokul Swaminathan of Merck researches potential vaccines that can train the body to recognize and kill a pathogen before it ever leads to an infection.

READ MORE

Researcher Profile: Rebecca Leary

Rebecca Leary works at the forefront of precision medicine, pursuing technologies that characterize cancer cells and their relationship with the body's own immune system.

READ MORE

Your Epilepsy Does Not Define You

Epilepsy patient, caregiver and advocate Loretta Boileau has seen firsthand the benefits of innovative treatments for her and her family, but knows there is still a long road ahead.

READ MORE

Researcher Profile: Christina Kiley

Through her roles at Eli Lilly and Company, Dr. Christina Kiley developed a strong understanding of the patient perspective and the diverse ways patients are incorporated into biopharmaceutical…

READ MORE

Researcher Profile: Eddy Han-Burgess

Eddy Han-Burgess and his team are using a mix of mathematical modeling, big data and artificial intelligence in hopes of more quickly identifying the unique characteristics of someone’s condition.

READ MORE

Researcher Profile: Henrik Klitgaard

With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy.

READ MORE

Disrupting Alzheimer's Disease

Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique challenges that make up Alzheimer's research and what the future holds for the 5.7 million Americans…

READ MORE

Taking Control of Epilepsy

As the most common serious neurological condition in the U.S., epilepsy affects roughly 3.4 million Americans. It's what drives biopharmaceutical researchers to fight back with innovative medicines…

READ MORE

Pursuing Novel and Targeted Treatments for Epilepsy

Epilepsy is a complex condition, and it will take an equally complex approach to put an end to the disease. America's biopharmaceutical companies will not be satisfied until that goal is reached.

READ MORE

Reflecting on the Progress in Managing Diabetes

While the economic toll of the disease remains high, our ability to understand and treat diabetes has progressed at a stunning rate over the past few decades.

READ MORE

Moving Toward a Value-Driven Health Care System

To advance a value-driven care system, we need better information, a focus on outcomes that matter to patients and flexible new approaches to paying for medicines.

READ MORE

Researcher Profile: David Cobden

Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford innovation by reading the story of David Cobden, Ph.D., who works to pursue new payment models for…

READ MORE

Researcher Profile: Michael Pride

To demonstrate the incredible work pursued by America's biopharmaceutical researchers, we're sharing the story of Dr. Michael Pride, a Pfizer scientist who is working on preventative vaccines for the…

READ MORE

Researcher Profile: Niranjana Nagarajan

According to Dr. Niranjana Nagarajan, a principal scientist at Celgene, "sheer curiosity" drove her into biopharmaceutical research.

READ MORE

Researcher Profile: Nils Lonberg

In his role as senior vice president of oncology biology discovery at Bristol-Myers Squibb, Dr. Lonberg leads a drug discovery group responsible for identifying potential immuno-oncology (I-O)…

READ MORE

HUBweek 2018: Why Innovation Needs Cross-Sector Collaboration

Innovation does not happen in a vacuum. Instead, it requires a rich ecosystem of talent, capital, expertise and logistics to translate theoretical science into life-saving treatments and therapies.

READ MORE

Researcher Profile: Doug Williamson

In recognition of the great work being done to treat mental illness, we're sharing the story of Doug Williamson, MD, the chief medical officer and vice president of US Medical at Lundbeck, who has a…

READ MORE

Breast Cancer Awareness Month: The Fight for New Treatments Continues

October is Breast Cancer Awareness Month, which each year calls attention to the condition that one in every eight women will face throughout their lifetimes.

READ MORE

Researcher Profile: Jay Fine

A new study shows there are more than 300 medicines in development to treat skin diseases. At Boehringer Ingelheim, researchers like Dr. Jay Fine are dedicated to finding innovative approaches to…

READ MORE

Innovation is Fragile, But Worth Protecting

The Atlantic, in partnership with PhRMA's GOBOLDLY campaign, convened thought leaders to discuss the policies needed to foster biopharmaceutical innovation while ensuring access and affordability for…

READ MORE

Blood Cancer Awareness Month: The Promise of Immunotherapy

September is Blood Cancer Awareness Month, which aims to raise awareness for patients with one of several types of blood cancer, including leukemia, lymphoma and myeloma.

READ MORE